Kevin Michael Lundquist insider trades

Open-market stock purchases and sales by Kevin Michael Lundquist, Chief Financial Officer at Outlook Therapeutics, Inc, from SEC Form 4 filings since Sep 1, 2026.

Recent trades

DateStockTradeValue
Sep 1, 2026OTLK Outlook Therapeutics, IncBought (not open market)—

Companies traded

  • OTLK Outlook Therapeutics, Inc: other filings, last Sep 1, 2026

Get free alerts when Kevin Michael Lundquist files a new trade →